CAAS
AZN icon

Capital Asset Advisory Services’s AstraZeneca AZN Stock Holding History

Capital Asset Advisory Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$462K Sell
2,303
-365
-14% -$70.4K 0.02% 195
2025
Q4 		$507K Sell
2,668
-28
-1% -$4.91K 0.02% 173
2025
Q3 		$414K Sell
2,696
-114
-4% -$17.3K 0.02% 194
2025
Q2 		$402K Buy
2,810
+106
+4% +$14.9K 0.02% 193
2025
Q1 		$391K Sell
2,704
-534
-16% -$77.3K 0.02% 194
2024
Q4 		$429K Buy
3,238
+50
+2% +$7K 0.02% 199
2024
Q3 		$490K Sell
3,188
-163
-5% -$26.3K 0.02% 187
2024
Q2 		$514K Buy
3,351
+871
+35% +$131K 0.03% 181
2024
Q1 		$335K Sell
2,480
-189
-7% -$25K 0.02% 230
2023
Q4 		$360K Sell
2,669
-18
-0.7% -$2.34K 0.02% 222
2023
Q3 		$365K Buy
2,687
+313
+13% +$42.8K 0.03% 224
2023
Q2 		$320K Sell
2,374
-390
-14% -$57.4K 0.02% 247
2023
Q1 		$384K Buy
2,764
+30
+1% +$4.04K 0.03% 228
2022
Q4 		$371K Sell
2,734
-112
-4% -$14K 0.03% 242
2022
Q3 		$312K Buy
2,846
+259
+10% +$32.9K 0.04% 237
2022
Q2 		$342K Buy
2,587
+175
+7% +$23K 0.04% 291
2022
Q1 		$320K Buy
+2,412
New +$289K 0.03% 314

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Capital Asset Advisory Services's AZN Position: Q1 2026 in Review

Capital Asset Advisory Services reduced its AstraZeneca (AZN) stake by 14% in Q1 2026, selling an estimated $70.4K and leaving 2,303 shares worth $462K. The position accounts for 0.02% of the portfolio, ranked #195.

Capital Asset Advisory Services first reported a position in AZN in Q1 2022 and has held it in 17 quarters since. The position peaked at $514K in Q2 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Capital Asset Advisory Services held 2,303 shares of AstraZeneca worth $462K as of Q1 2026.
  • Capital Asset Advisory Services sold 365 AstraZeneca shares in Q1 2026, an estimated $70.4K.
  • AstraZeneca made up 0.02% of Capital Asset Advisory Services's portfolio in Q1 2026, its #195 holding.
  • Capital Asset Advisory Services first reported a position in AstraZeneca in Q1 2022 and has held it in 17 quarters since.
  • Capital Asset Advisory Services's AstraZeneca position peaked at $514K in Q2 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Capital Asset Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.